<script> window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'UA-48293608-1'); </script>
Logo-bi
Bioimpacts. 2025;15: 32630 | Published on: 2025 Dec 14. doi: 10.34172/bi.32630
PMID: 41716515        PMCID: PMC12913208

Review

Targeted therapy for liver cancer: Current status and future directions

Qian Wang 1 * ORCID

Cited by CrossRef: 0


1- Liu X, Gao X, Yang Y, Yang D, Sun Y, Yang Y, Zhao T, Li N. Unraveling regorafenib resistance: metabolic reprogramming, tumor plasticity, and novel approaches to overcome therapy failure. Arch Pharm Res. 2026;49(4):475 [Crossref]

Poster

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate (2024): 19% 
Publication fee: Free of charge


Indexing/Abstracting Info
PubMedPubMed Central; Scopus; Science Citation Index Expanded; Google Scholar;   SJR; Essential Science IndicatorsEmbase; EBSCOhost; CAS: DOAJSHERPA/RoMEO
Member of   
Follower of ICMJE
Permission: Creative Commons